English
Home > Products > 3828-49-7

China 3828-49-7 Factory

We are commitment to offer the competitive price ,outstanding products quality, as well as fast delivery for 3828-49-7,CAS NO 3828-49-7,2,3-Difluorotoluene, We have ISO 9001 Certification and qualified this product or service .in excess of 16 years experiences in manufacturing and designing, so our goods featured with very best high-quality and aggressive rate. Welcome cooperation with us!
3828-49-7, High output volume, top quality, timely delivery and your satisfaction are guaranteed. We welcome all inquiries and comments. We also present agency service---that act as the agent in china for our customers. If you are interested in any of our products and solutions or have an OEM order to fulfill, make sure you feel free to contact us now. Working with us will save you money and time.

Related Products

Hot Products

  • Allopurinol

    Allopurinol

    Product Name:Allopurinol
    Molecular Formula:C5H4N4O
    Molecular Weight;136.11
    CAS Registry Number;315-30-0
  • 1,5-Pentanediol diacrylate

    1,5-Pentanediol diacrylate

    Product Name:1,5-Pentanediol diacrylate
    Molecular Formula:C11H16O4
    Molecular Weight:212.24
    CAS Registry Number:36840-85-4
  • Ivosidenib

    Ivosidenib

    Product Name:Ivosidenib
    Molecular Formula:C28H22ClF3N6O3
    Molecular Weight;582.96
    CAS Registry Number;1448347-49-6
  • Estradiol benzoate

    Estradiol benzoate

    Product Name:Estradiol benzoate
    Molecular Formula:C25H28O3
    Molecular Weight:376.5
    CAS Registry Number;50-50-0
  • Bleomycin hydrochloride

    Bleomycin hydrochloride

    Product Name:Bleomycin hydrochloride
    Molecular Formula:C50H71N16O21S2R.x(HCl)
    Molecular Weight;1451.00
    CAS Registry Number;67763-87-5
  • 2,6-dichloro-5-fluoro-N-((2-isopropyl-4-methylpyridin-3-yl)carbamoyl)nicotinamide

    2,6-dichloro-5-fluoro-N-((2-isopropyl-4-methylpyridin-3-yl)carbamoyl)nicotinamide

    Product Name:2,6-dichloro-5-fluoro-N-((2-isopropyl-4-methylpyridin-3-yl)carbamoyl)nicotinamide
    Molecular Formula:C16H15Cl2FN4O2
    Molecular Weight:385.22
    CAS Registry Number:2252403-81-7
  • Related Blog
  • Reviews

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • What Is Misoprostol Used For?

    Misoprostol, a derivative of prostaglandin E1, can be used in the treatment of duodenal ulcer, the prevention of anti-inflammatory induced peptic ulcer and the prevention of early pregnancy.It has the function of inhibiting the secretion of gastric acid and preventing the formation of ulcer, thus protecting the gastric mucosa...

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 3828-49-7

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept